Riskpilot← Back to searchSign inGet full accessDocLibera AB
ABActiveOrg 5594063934Anckargripsgatan 3General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2025
SEK 8,2M
+99% vs 2024
EBITDA margin
31.4%
+152% vs 2024
Equity ratio
53.5%
Financial strength
Net profit 2025
SEK 2,1M
+154% vs 2024
| Revenue | SEK 8,2M | +99% |
| EBITDA | SEK 2,6M | +152% |
| Net profit | SEK 2,1M | +154% |
| Total assets | SEK 4M | +87% |
| Equity | SEK 2,1M | +143% |
| Employees | 0 | — |
Legal name
DocLibera AB
Org number
5594063934
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 november 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ägnar sig åt medicinsk hälso- och sjukvård på distans via digitala plattformar och vid fysiska vårdinrättningar samt därmed förenlig verksamhet. Bolaget utför bemanningsuppdrag på konsultbasis inom hälso- och sjukvård och förmedling av sådana uppdrag samt därmed förenlig verksamhet.
Address
Anckargripsgatan 3
Email
hello@getayd.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 800 | 4 121 | 8 211 |
| Staff expenses | — | — | — |
| EBITDA | 81 | 1 023 | 2 577 |
| Depreciation & amort. | — | — | −0 |
| EBIT | 81 | 1 023 | 2 577 |
| Net financials | — | 3 | 6 |
| Profit before tax | 60 | 1 026 | 2 603 |
| Tax | −13 | −218 | −549 |
| Net profit | 47 | 808 | 2 054 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 316 | 2 132 | 3 993 |
| Equity | 72 | 880 | 2 137 |
| Long-term debt | — | — | 0 |
| Short-term debt | 223 | 1 231 | 1 855 |
| Total debt | 223 | 1 231 | 1 855 |
EBITDA margin
31.4%
This company
15.8%
Market median
+99% vs market
20232025
Equity ratio
53.5%
This company
38.2%
Market median
+40% vs market
20232025
Return on equity
96.1%
This company
18.4%
Market median
+422% vs market
20232025
Net profit margin
25.0%
This company
8.1%
Market median
+209% vs market
20232025
Asset turnover
2.06×
This company
1.12×
Market median
+84% vs market
20232025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DÅ | Audit | 2026 |
| Former (3) | ||
FL Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2026 |
DO Chief Executive Officer | Chief Executive Officer | 2022 – 2026 |
OR | Audit | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DocLibera AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Lars Magnus Åhlander | Deputy Chief Executive Officer | 0 companies |
| David Åke Allan Eskilsson | Audit | 0 companies |
| Daniel Oskar Erik Önefäldt | Chief Executive Officer | 0 companies |
| Olof Rikard Zachrisson | Audit | 0 companies |
| Emma Carin Cecilia Flodin | Deputy Board Member | 0 companies |
| Jakob Magnus Wikefeldt | Board of Directors | 0 companies |
| Markus Eric Andersson | Board of Directors | 0 companies |
| Carl Johan Flodin | Chairman | 0 companies |
| Patrick Gustaf Michael Sterner | Chairman | 0 companies |